Progressive Corporation
PGR
$194.13
-2.88%
The Progressive Corporation is a major US property and casualty insurer, primarily underwriting private and commercial auto insurance, with a growing presence in homeowners insurance. It is a market leader and a pioneer in the direct-to-consumer insurance channel, known for its data-driven pricing and marketing efficiency. The current investor narrative centers on the stock's significant underperformance relative to the broader market, driven by concerns over rising claims costs (severity) in the auto insurance sector and the impact of a potential economic slowdown on policy growth, making it a focal point for debates on value versus fundamental headwinds.…
PGR
Progressive Corporation
$194.13
Related headlines
Investment Opinion: Should I buy PGR Today?
Rating & Thesis: Hold. PGR is a high-quality company caught in a difficult sector cycle, trading at a compelling valuation, but lacking a near-term catalyst for a rerating. The mixed analyst sentiment, with ratings from Underweight to Buy, reflects this stalemate between value and momentum.
Supporting Evidence: The stock is cheap on an absolute and growth-adjusted basis, with a trailing PE of 11.81x and a PEG ratio of 0.35. Revenue growth remains robust at 12.19% YoY, and profitability is strong with a 12.98% net margin and exceptional FCF generation of $17.2B. However, these strengths are counterbalanced by a severe -30.57% one-year price decline, negative momentum across all measured periods, and high short interest (short ratio 2.22), indicating the market is focused on cyclical risks over fundamental value.
Risks & Conditions: The two biggest risks are a further deterioration in auto insurance margins and a break below the $192 technical support, which could trigger another leg down. This Hold would upgrade to a Buy if quarterly gross margins stabilize above 25% for two consecutive quarters, signaling the claims cycle has turned, or if the price establishes a firm base above $210. It would downgrade to a Sell if revenue growth decelerates below 5% or if the stock decisively breaks the $192 support on high volume. Relative to its own history, the stock is undervalued, but it may remain so until the sector outlook improves.
Sign up to view all
PGR 12-Month Price Forecast
PGR presents a classic battle between value and momentum. The fundamentals—growth, profitability, cash flow—are strong and support a much higher valuation. However, the stock is in a pronounced downtrend with no clear technical bottom, reflecting legitimate concerns about the auto insurance cycle. The neutral stance reflects the high probability (50%) of a base-case range-bound scenario, where these opposing forces cancel out. The stance would upgrade to bullish on evidence of margin stabilization (two quarters >25% gross margin) and would downgrade to bearish on a confirmed break below $192 with deteriorating fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Progressive Corporation's 12-month outlook, with a consensus price target around $252.37 and implied upside of +30.0% versus the current price.
Average Target
$252.37
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$155 - $252
Analyst target range
Analyst coverage for Progressive appears limited based on the provided data, with only 2 analysts contributing to the estimates for earnings and revenue. This suggests that while it is a large-cap company, the analyst consensus may not be as broad or frequently updated as for other mega-caps, which can lead to higher volatility. The institutional ratings data shows a mix of opinions among the firms that do cover it, with recent actions including a 'Buy' from B of A Securities, 'Hold' or 'Neutral' from Jefferies, UBS, Mizuho, and KBW, and an 'Underweight' from Morgan Stanley. This indicates a consensus that leans neutral to slightly bullish, but with notable bearish dissent. A full target price range and average are not provided in the data, so the implied upside or downside cannot be calculated. The wide dispersion in recommendations (from Underweight to Buy) signals higher uncertainty and debate among analysts regarding the company's near-term prospects, likely tied to the auto insurance cycle and macroeconomic concerns.
Bulls vs Bears: PGR Investment Factors
The evidence currently tilts slightly bullish, primarily on valuation and financial strength, but the bear case is powerfully supported by persistent technical weakness and fundamental uncertainty. The single most important tension in the investment debate is whether PGR's current low valuation (11.81x PE, 0.35 PEG) accurately prices in the risks of the auto insurance cycle, or if it represents a profound mispricing of a market leader's durable earnings power. The resolution hinges on the trajectory of claims severity and the company's next few quarterly margins.
Bullish
- Extreme Undervaluation on PE and PEG: The stock trades at a trailing PE of 11.81x, near the bottom of its historical range, and a forward PE of 12.11x. The PEG ratio of 0.35, based on 12.19% revenue growth, signals the market is severely discounting future growth, creating a classic value opportunity.
- Exceptional Financial Strength and Cash Flow: The company generates massive free cash flow ($17.2B TTM), supporting a 2.15% dividend yield and share repurchases. With a net margin of 12.98% and ROE of 247.66%, its core profitability remains robust despite sector headwinds.
- Strong Revenue Growth Amid Downturn: Q4 2025 revenue grew 12.19% YoY to $22.74B, demonstrating resilient policyholder demand. The Personal Lines segment, at $18.71B, is the primary engine, showing the company's market leadership is intact.
- Technical Support Near 52-Week Low: Trading at $195.25, just 1.7% above its 52-week low of $192.02, the stock is pricing in extreme pessimism. This positioning, combined with a low beta of 0.33, suggests the decline is stock-specific and may have overshot fundamentals.
Bearish
- Severe and Sustained Price Downtrend: The stock is down 30.57% over the past year and 7.95% over the past three months, significantly underperforming the SPY (+22.2% and -4.0%, respectively). This persistent selling pressure reflects deep-seated concerns over auto insurance fundamentals.
- High Volatility in Profit Margins: Gross margin swung from 29.28% in Q4 2025 to 15.76% in Q3 2025, highlighting sensitivity to claims costs. This earnings volatility makes the stock risky and complicates valuation, as seen in the wide analyst rating dispersion from Underweight to Buy.
- Concentration in Cyclical Auto Insurance: Over 82% of revenue comes from the Personal Lines (auto) segment, making PGR highly exposed to auto insurance cycle risks like claims severity inflation and potential recession-driven policy lapses. This lack of diversification amplifies sector-specific headwinds.
- Elevated Short Interest and Analyst Skepticism: A short ratio of 2.22 indicates significant bearish bets. Analyst consensus is mixed, with firms like Morgan Stanley rating it Underweight, signaling high uncertainty and debate about the company's ability to navigate near-term challenges.
PGR Technical Analysis
The prevailing price trend for Progressive is a pronounced and sustained downtrend, with the stock down 30.57% over the past year. As of the latest close of $195.25, the stock is trading near the bottom of its 52-week range, at approximately 67% of the distance from its 52-week low of $192.02 to its high of $289.96. This positioning near the lows suggests the market is pricing in significant pessimism, presenting a potential value opportunity, though it also risks being a 'falling knife' if fundamental pressures persist. Recent short-term momentum shows continued weakness, with the stock down 8.48% over the past month and 7.95% over the past three months, aligning with and reinforcing the longer-term downtrend. This consistent negative momentum indicates selling pressure has not abated. The stock's beta of 0.327 indicates it has been significantly less volatile than the broader market (SPY) during this period, which is unusual for a downtrend of this magnitude and may suggest the decline has been driven by stock-specific fundamental concerns rather than broad market risk-off sentiment. Key technical levels are clearly defined, with immediate support at the 52-week low of $192.02 and major resistance far above at the 52-week high of $289.96. A decisive break below the $192 support could trigger another leg down, while any sustained recovery would need to overcome a substantial overhead supply of shares purchased at higher prices.
Beta
0.33
0.33x market volatility
Max Drawdown
-33.6%
Largest decline past year
52-Week Range
$192-$290
Price range past year
Annual Return
-28.9%
Cumulative gain past year
| Period | PGR Return | S&P 500 |
|---|---|---|
| 1m | -3.5% | +0.5% |
| 3m | -9.8% | -2.1% |
| 6m | -19.1% | +4.0% |
| 1y | -28.9% | +29.5% |
| ytd | -8.5% | -0.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGR Fundamental Analysis
Progressive's revenue trajectory remains robustly positive, with Q4 2025 revenue of $22.74 billion representing a 12.19% year-over-year growth rate. This growth is being driven primarily by the massive Personal Lines Segment, which generated $18.71 billion in the latest period, compared to $2.68 billion from Commercial Lines. The company is highly profitable, with Q4 2025 net income of $2.95 billion and a net margin of 12.98%. However, profitability metrics show some quarterly variability; for instance, the gross margin was 29.28% in Q4 2025, up from 15.76% in Q3 2025, indicating potential volatility in claims experience and pricing adequacy. The balance sheet and cash flow position is exceptionally strong, characterized by substantial internal cash generation. The company reported trailing twelve-month free cash flow of $17.2 billion. Key health metrics include a Return on Equity (ROE) of 247.66% and a Return on Assets (ROA) of 7.92%, though these elevated figures are partly a function of the insurance industry's leverage and capital structure. The strong free cash flow supports the company's ability to fund growth, pay dividends (with a 2.15% yield), and repurchase shares without reliance on external financing, significantly mitigating financial risk.
Quarterly Revenue
$22.7B
2025-12
Revenue YoY Growth
+0.12%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$17.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGR Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Progressive trades at a trailing PE of 11.81x and a forward PE of 12.11x based on analyst estimates. The minimal gap between trailing and forward multiples suggests the market expects earnings to be roughly stable in the near term. Compared to sector averages (data not provided in the input), a specific premium or discount cannot be quantified, but a sub-12x PE for a company with this growth and profitability profile appears inexpensive on an absolute basis, especially considering its PEG ratio of 0.35. Historically, the stock's current trailing PE of 11.81x sits at the very low end of its own historical range observed in the data, which has seen quarterly PE ratios fluctuate from single digits to over 50x in recent years. For context, the PE ratio was 29.24x as recently as Q4 2025 according to the historical ratios data. Trading near historical valuation lows suggests the market is pricing in significant fundamental deterioration or a sustained period of depressed earnings, creating a potential value opportunity if the company's earnings power proves more resilient than feared.
PE
11.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -31x~137x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Progressive's primary financial risk is earnings volatility driven by claims severity in its concentrated auto insurance business, as evidenced by the gross margin swing from 15.76% to 29.28% between Q3 and Q4 2025. While the balance sheet is fortress-like with $17.2B in TTM FCF, the company's valuation (11.81x PE) is dependent on maintaining its high profitability (12.98% net margin). A sustained period of elevated claims costs could compress margins and trigger earnings downgrades, challenging the low-PE valuation thesis. Revenue concentration is a key risk, with over 82% derived from Personal Lines, leaving it overly exposed to a single, cyclical product line.
Market & Competitive Risks: The stock faces significant valuation compression risk; it trades near its 52-week low while the market (SPY) is up 22% over the past year, indicating severe de-rating. Its low beta of 0.327 suggests this underperformance is stock-specific, driven by sector concerns rather than broad market moves. Competitive and regulatory pressures in auto insurance could limit pricing power, while an economic slowdown could dampen policy growth. The wide dispersion in analyst ratings (Underweight to Buy) reflects high uncertainty and the potential for negative sentiment to persist, preventing a valuation re-rating even if fundamentals stabilize.
Worst-Case Scenario: The worst-case scenario involves a severe recession coupled with a structural rise in auto repair and medical costs, leading to a prolonged period of underwriting losses. This could trigger consecutive earnings misses, dividend cuts, and a loss of market share. In this adverse scenario, the stock could breach its 52-week low of $192.02 and approach levels implied by its maximum drawdown of -33.6%, which would target approximately $192. This suggests a realistic downside of about -35% from the recent close near $240 in October 2025 to the current support zone, implying a potential loss to the $192-$195 range.
FAQ
The key risks are, in order of severity: 1) Operational Risk: High exposure to auto insurance claims severity, causing volatile profitability (gross margin swung 14pp last quarter). 2) Market Sentiment Risk: Persistent negative price momentum (-30.57% YoY) and high short interest (ratio 2.22) can prolong undervaluation. 3) Concentration Risk: Over 82% of revenue from Personal Lines (auto), lacking diversification. 4) Valuation Trap Risk: The low PE may not be a floor if earnings estimates are cut, leading to further price declines.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees range-bound trading between $210-$240 as headwinds and value balance out. The Bull Case (30% probability) targets $260-$290 on margin recovery and a valuation rerating. The Bear Case (20% probability) warns of a drop to $180-$192 if fundamentals worsen. The base case is most likely, assuming the challenging but stable auto insurance environment persists. The key assumption is that revenue growth remains above 10% while margins remain volatile.
PGR is significantly undervalued based on traditional metrics relative to its own history and growth profile. Its trailing PE of 11.81x is near the bottom of its historical range and its PEG ratio of 0.35 is exceptionally low, implying the market is paying very little for its 12.19% growth. Compared to the broader market, it trades at a deep discount. The valuation implies the market expects earnings to deteriorate or remain stagnant, pricing in a worst-case scenario for the auto insurance cycle.
PGR is a good buy for value investors with a multi-year horizon who believe the auto insurance cycle will eventually turn. At a PE of 11.81x and PEG of 0.35, the stock is statistically cheap for a company growing revenue at 12.19% with $17.2B in annual free cash flow. The key risk is timing; the stock could remain depressed if claims costs stay elevated. It is not a good buy for short-term traders or those sensitive to volatility, given its 30% decline over the past year and lack of positive momentum.
PGR is suitable for long-term investment, not short-term trading. Its low beta (0.33) and high free cash flow support a stable, long-term holding, but the severe near-term volatility and lack of positive momentum make it a poor trading vehicle. The valuation opportunity requires patience for the market to recognize the disconnect between price and fundamentals, which may take several quarters. A minimum holding period of 2-3 years is suggested to ride out the auto insurance cycle and capture the potential valuation mean reversion.